Regulation of antigen presentation and cross-presentation in the dendritic cell network: Facts, hypothesis, and immunological implications

被引:126
|
作者
Wilson, NS [1 ]
Villadangos, JA
机构
[1] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic 3050, Australia
[2] Walter & Eliza Hall Inst Med Res, Cooperat Res Ctr Vaccine Technol, Parkville, Vic 3050, Australia
来源
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0065-2776(04)86007-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Dendritic cells (DCs) are central to the maintenance of immunological tolerance and the initiation and control of immunity. The antigen-presenting properties of DCs enable them to present a sample of self and foreign proteins, contained within an organism at any given time, to the T-cell repertoire. DCs achieve this communication with T cells by displaying antigenic peptides bound to MHC I and MHC II molecules. Here we review the studies carried out over the past 15 years to characterize these antigen presentation mechanism, emphasizing their significance in relation to DC function in vivo. The life cycles of different DC populations found in vivo are described. Furthermore, we provide a critical assessment Of the studies that examine the mechanisms controlling DC MHC class II antigen presentation, which have often reached contradictory conclusions. Finally, we review findings pertaining to the biological mechanisms that enable DCs to present exogenous antigens on their MHC class I molecules, a process known as cross-presentation. Throughout, we highlight what we consider to be major knowledge gaps in the field and speculate on possible directions for future research.
引用
收藏
页码:241 / 305
页数:65
相关论文
共 50 条
  • [41] Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation
    Burgdorf, Sven
    Schoelz, Christian
    Kautz, Andreas
    Tampe, Robert
    Kurts, Christian
    NATURE IMMUNOLOGY, 2008, 9 (05) : 558 - 566
  • [42] Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy
    D E Orange
    M Jegathesan
    N E Blachère
    M O Frank
    H I Scher
    M L Albert
    R B Darnell
    Prostate Cancer and Prostatic Diseases, 2004, 7 : 63 - 72
  • [43] Effective antigen cross-presentation by prostate cancer patients' dendritic cells:: implications for prostate cancer immunotherapy
    Orange, DE
    Jegathesan, M
    Blachère, NE
    Frank, MO
    Scher, HI
    Albert, ML
    Darnell, RB
    PROSTATE CANCER AND PROSTATIC DISEASES, 2004, 7 (01) : 63 - 72
  • [44] Remodeling of the endosomal pathway during antigen cross-presentation by human dendritic cells
    Compeer, Ewoud
    Flinsenberg, Thijs
    Boes, Marianne
    MOLECULAR IMMUNOLOGY, 2012, 51 (01) : 10 - 10
  • [45] Fcγ receptors and cross-presentation in dendritic cells
    Amigorena, S
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01): : F1 - F3
  • [46] DENDRITIC CELLS Assessing cross-presentation in vivo
    Allan, Sarah
    NATURE REVIEWS IMMUNOLOGY, 2009, 9 (01) : 7 - 7
  • [47] Molecular and cell-biological mechanisms of antigen cross-presentation
    Kurts, Christian
    FRONTIERS IN IMMUNOLOGY, 2013, 4
  • [48] Cross-Presentation in Mouse and Human Dendritic Cells
    Segura, Elodie
    Amigorena, Sebastian
    ADVANCES IN IMMUNOLOGY, VOL 127, 2015, 127 : 1 - 31
  • [49] Measuring the molecular mechanisms of tumor antigen cross-presentation in dendritic cells and macrophages
    Muntjewerff, Elke M.
    Bianchi, Frans
    Maassen, Sjors
    van den Bogaart, Geert
    JOURNAL OF IMMUNOLOGY, 2019, 202 (01):
  • [50] β2-Adrenoreceptor Agonist Inhibits Antigen Cross-Presentation by Dendritic Cells
    Herve, Julie
    Dubreil, Laurence
    Tardif, Virginie
    Terme, Mickael
    Pogu, Sylvie
    Anegon, Ignacio
    Rozec, Bertrand
    Gauthier, Chantal
    Bach, Jean-Marie
    Blancou, Philippe
    JOURNAL OF IMMUNOLOGY, 2013, 190 (07): : 3163 - 3171